Page last updated: 2024-08-22

valnoctamide and valproic acid

valnoctamide has been researched along with valproic acid in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.00)18.7374
1990's4 (16.00)18.2507
2000's6 (24.00)29.6817
2010's14 (56.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bialer, M; Devor, M; Kaufmann, D; Shimshoni, JA; Yagen, B1
Barzaghi, N; Bialer, M; Haj-Yehia, A; Perucca, E; Pisani, F1
Bialer, M; Haj-Yehia, A1
Bergman, F; Bialer, M; Blotnik, S1
Bialer, M; Ehlers, K; Nau, H; Radatz, M; Yagen, B1
Bialer, M1
Bialer, M; Haj-Yehia, A; Hurst, SI; Kroetz, DL; Levi, M; Levy, RH; Spiegelstein, O; Yagen, B1
Bialer, M; Ebinger, G; Khan, GM; Lindekens, H; Michotte, Y; Smolders, I1
Aoki, Y; Bialer, M; Fujiwara, M; Kurihara, H; Okada, A1
Aoki, Y; Bialer, M; Fujiwara, M; Kurihara, H; Kushima, K; Okada, A1
Aoki, Y; Bialer, M; Fujiwara, M; Kushima, K; Okada, A1
Agam, G; Applebaum, J; Belmaker, RH; Bersudsky, Y; Gaiduk, Y; Mishory, A; Podberezsky, A; Sharony, L1
Alex, AB; Bialer, M; Hen, N; Kaufmann, D; McDonough, JH; Pollock, A; Shekh-Ahmad, T; Stables, JP; White, HS; Wilcox, KS; Yagen, B1
Bialer, M; Dudek, FE; Hen, N; Kaufmann, D; Nelson, C; Pouliot, W; Ricks, K; Roach, B; Shekh-Ahmad, T; Yagen, B1
Bialer, M; Hen, N; Kubová, H; Mareš, P; Yagen, B1
Bialer, M; Nanau, RM; Neuman, MG; Shekh-Ahmad, T; Yagen, B1
Bialer, M; Hen, N; McDonough, JH; Shekh-Ahmad, T; Yagen, B1
Bialer, M; Finnell, RH; Hen, N; McDonough, JH; Shekh-Ahmad, T; Wlodarczyk, BJ; Yagen, B1
Basselin, M; Modi, HR; Rapoport, SI1
Bialer, M; Finnell, RH; Mawasi, H; Shekh-Ahmad, T; Wlodarczyk, BJ1
Bialer, M; Mawasi, H; McDonough, JH; Shekh-Ahmad, T; Yagen, B1
Davis, JN; Gorres, KL; Miller, G; Ornaghi, S; Paidas, MJ; van den Pol, AN1
Bialer, M; Eisenkraft, A; Elger, CE; Kudin, AP; Kunz, WS; Mawasi, H1
Bialer, M; Cabrera, RM; Finnell, RH; Lin, YL; Wlodarczyk, BJ1
Bello-Morales, R; de Castro, F; López-Guerrero, JA; Praena, B1

Reviews

1 review(s) available for valnoctamide and valproic acid

ArticleYear
The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.
    Epilepsy & behavior : E&B, 2015, Volume: 49

    Topics: Amides; Animals; Anticonvulsants; Humans; Status Epilepticus; Stereoisomerism; Valproic Acid

2015

Trials

1 trial(s) available for valnoctamide and valproic acid

ArticleYear
Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial.
    Bipolar disorders, 2010, Volume: 12, Issue:4

    Topics: Adult; Amides; Animals; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mice; Middle Aged; Placebos; Pregnancy; Psychiatric Status Rating Scales; Risperidone; Teratogens; Treatment Outcome; Valproic Acid

2010

Other Studies

23 other study(ies) available for valnoctamide and valproic acid

ArticleYear
Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
    Journal of medicinal chemistry, 2009, Nov-26, Volume: 52, Issue:22

    Topics: Amides; Animals; Anticonvulsants; Electroshock; Isomerism; Male; Mice; Pain; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures; Spinal Nerves; Urea; Valproic Acid

2009
Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects.
    European journal of clinical pharmacology, 1990, Volume: 38, Issue:3

    Topics: Adult; Amides; Half-Life; Humans; Isomerism; Male; Valproic Acid

1990
Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs.
    Journal of pharmaceutical sciences, 1988, Volume: 77, Issue:10

    Topics: Administration, Oral; Amides; Animals; Anticonvulsants; Dogs; Female; Half-Life; Injections, Intravenous; Male; Protein Binding; Valproic Acid

1988
Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:5

    Topics: Amides; Animals; Anti-Anxiety Agents; Anticonvulsants; Brain; Liver; Male; Rats; Tissue Distribution; Valproic Acid

1996
Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
    Epilepsy research, 1998, Volume: 30, Issue:1

    Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Body Weight; Embryo, Mammalian; Female; Fetal Death; Mice; Mice, Inbred Strains; Pentanoic Acids; Pregnancy; Teratogens; Valproic Acid

1998
Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
    Journal of controlled release : official journal of the Controlled Release Society, 1999, Nov-01, Volume: 62, Issue:1-2

    Topics: Amides; Animals; Anticonvulsants; Biotransformation; Cyclopropanes; Dogs; Drug Design; Glycine; Mice; Rats; Rats, Sprague-Dawley; Valproic Acid

1999
Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Pharmaceutical research, 2000, Volume: 17, Issue:2

    Topics: Amides; Anti-Anxiety Agents; Anticonvulsants; Epoxide Hydrolases; Ethylene Glycols; Humans; Isomerism; Liver; Microsomes; Structure-Activity Relationship; Valproic Acid

2000
In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy.
    Pharmaceutical research, 2000, Volume: 17, Issue:11

    Topics: Amides; Animals; Anti-Anxiety Agents; Anticonvulsants; Epilepsies, Partial; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Male; Microdialysis; Muscarinic Agonists; Pilocarpine; Rats; Rats, Wistar; Valproic Acid

2000
Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2004, Volume: 71, Issue:1

    Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Bone and Bones; Cartilage; Cesarean Section; Female; Fetus; Male; Mice; Molecular Structure; Neural Tube Defects; Valproic Acid

2004
Polycomb homologs are involved in teratogenicity of valproic acid in mice.
    Birth defects research. Part A, Clinical and molecular teratology, 2004, Volume: 70, Issue:11

    Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Bone and Bones; DNA-Binding Proteins; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Gene Silencing; Histone-Lysine N-Methyltransferase; Injections, Subcutaneous; Male; Mice; Myeloid-Lymphoid Leukemia Protein; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Pregnancy; Proto-Oncogenes; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Valproic Acid; Zinc Fingers

2004
Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Birth defects research. Part A, Clinical and molecular teratology, 2005, Volume: 73, Issue:4

    Topics: Abnormalities, Drug-Induced; Amides; Animals; Embryo, Mammalian; Female; Gene Expression; Gene Expression Profiling; Immediate-Early Proteins; Mice; Neural Tube Defects; Oligonucleotide Array Sequence Analysis; Pregnancy; Valproic Acid

2005
A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
    Epilepsia, 2012, Volume: 53, Issue:1

    Topics: Amides; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Hippocampus; Male; Mice; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Seizures; Status Epilepticus; Time Factors; Treatment Outcome; Valproic Acid

2012
A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus.
    Neuroscience, 2013, Feb-12, Volume: 231

    Topics: Amides; Animals; Anticonvulsants; Cerebral Cortex; Diazepam; Dose-Response Relationship, Drug; Electroencephalography; Male; Pentobarbital; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid

2013
Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats.
    Epilepsy research, 2013, Volume: 106, Issue:1-2

    Topics: Aging; Allylisopropylacetamide; Amides; Animals; Anticonvulsants; Convulsants; Epilepsy, Generalized; Male; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Stereoisomerism; Valproic Acid

2013
Valproic acid derivatives signal for apoptosis and repair in vitro.
    Clinical biochemistry, 2013, Volume: 46, Issue:15

    Topics: Amides; Apoptosis; Cell Line, Tumor; Cell Survival; Cells, Cultured; DNA Repair; Drug Hypersensitivity Syndrome; Gene Expression; Hepatocytes; Humans; Inflammation; Interferon-gamma; Interleukin-1; Interleukin-6; Keratin-18; Lymphocytes; Signal Transduction; Tumor Necrosis Factor-alpha; Valproic Acid

2013
Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.
    Epilepsia, 2013, Volume: 54 Suppl 6

    Topics: Acute Disease; Amides; Animals; Anticonvulsants; Disease Models, Animal; Guinea Pigs; Humans; Rats; Seizures; Status Epilepticus; Treatment Outcome; Valproic Acid

2013
Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.
    Epilepsia, 2014, Volume: 55, Issue:2

    Topics: Amides; Animals; Anticonvulsants; Central Nervous System Stimulants; Male; Mice; Neural Tube Defects; Random Allocation; Rats; Rats, Sprague-Dawley; Status Epilepticus; Stereoisomerism; Teratogens; Valproic Acid

2014
Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.
    Bipolar disorders, 2014, Volume: 16, Issue:8

    Topics: Amides; Arachidonic Acid; Coenzyme A Ligases; Dose-Response Relationship, Drug; Enzyme Activation; In Vitro Techniques; Iodine Isotopes; Models, Statistical; Valproic Acid

2014
Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid.
    Epilepsy & behavior : E&B, 2015, Volume: 46

    Topics: Amides; Animals; Anticonvulsants; Female; Isomerism; Male; Mice; Mice, Transgenic; Rats; Rats, Sprague-Dawley; Seizures; Valproic Acid

2015
Mood stabilizers inhibit cytomegalovirus infection.
    Virology, 2016, Volume: 499

    Topics: Amides; Animals; Cell Line; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Disease Models, Animal; Female; Humans; Male; Mice; Muromegalovirus; Tranquilizing Agents; Valproic Acid; Viral Load; Virus Replication

2016
Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase.
    International journal of molecular sciences, 2017, Sep-06, Volume: 18, Issue:9

    Topics: Amides; Animals; Dihydrolipoamide Dehydrogenase; Liver; Mitochondria; Mitochondria, Liver; Pyruvic Acid; Rats; Valproic Acid

2017
Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
    Birth defects research, 2019, 08-15, Volume: 111, Issue:14

    Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Female; Fetal Death; Fetus; Mice; Neural Tube Defects; Pregnancy; Teratogenesis; Teratogens; Teratoma; Valproic Acid

2019
Amidic derivatives of valproic acid, valpromide and valnoctamide, inhibit HSV-1 infection in oligodendrocytes.
    Antiviral research, 2019, Volume: 168

    Topics: Amides; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Herpesvirus 1, Human; Humans; Molecular Structure; Oligodendroglia; Rats; Valproic Acid; Viral Proteins; Virus Internalization; Virus Replication

2019